← Evidence map

ArticleHematology. American Society of Hematology. Education Program2024

Should we use bisphosphonates to treat bone complications in sickle cell disease?

Jahnavi Gollamudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39644017